Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00262-006-0181-3, but it redirected us to https://link.springer.com/article/10.1007/s00262-006-0181-3. The analysis below is for the second page.

Title[redir]:
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma | Cancer Immunology, Immunotherapy
Description:
Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.

Matching Content Categories {📚}

  • Telecommunications
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,904,851 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure how the site profits.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, google, scholar, cancer, pubmed, cas, cells, immunotherapy, macrophages, cellular, bartholeyns, vivo, cell, patients, tracking, activated, ovarian, mak, access, sites, carcinoma, monocytes, oncol, immunol, privacy, cookies, content, macrophage, prince, chokri, human, poindron, immunother, data, publish, research, search, killer, ritchie, mileshkin, wall, distribution, tumour, open, clin, clinical, adoptive, melbourne, information, log,

Topics {✒️}

month download article/chapter bispecific antibody mdx-h210 mdx-h210 bispecific antibody imaging cell trafficking human-activated macrophages produced large scale isolation induce anti-tumour responses stem cells article cancer immunology administered mak cells vivo cell labeling full article pdf privacy choices/manage cookies improved pet labels related subjects human macrophages produced activated macrophages proliferating activated macrophages grown metastatic ovarian carcinoma cellular cancer immunotherapies cell labelling epithelial ovarian carcinoma counterflow centrifugation elutriation car macrophages directs indium-labelled macrophages scope submit manuscript generating high numbers multi-dimensional characterization cytokine secretion profile human monocytes cultured anti-tumor properties de gramont topoisomerase ii-alpha romet-lemonne jl infarcted human myocardium 64cu-pyruvaldehyde-bis positron-emission tomography 6th framework programme diagnostic imaging conditions privacy policy potent antitumoral properties adoptive cellular immunotherapy cell radiolabelling european economic area demonstrate successful targeting human blood monocytes 18f-fdg limited 18f-fdg labelling cd64-directed immunotherapy compared antitumoral effects

Schema {🗺️}

WebPage:
      mainEntity:
         headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
         description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
         datePublished:2006-05-30T00:00:00Z
         dateModified:2006-05-30T00:00:00Z
         pageStart:155
         pageEnd:163
         sameAs:https://doi.org/10.1007/s00262-006-0181-3
         keywords:
            Immunotherapy
            Macrophage
            Radiolabel
            PET
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:56
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:D. Ritchie
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:University of Melbourne
                     address:
                        name:University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L. Mileshkin
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:University of Melbourne
                     address:
                        name:University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Wall
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Bartholeyns
               affiliation:
                     name:Immuno-Designed Molecules
                     address:
                        name:Immuno-Designed Molecules, Paris, France
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Thompson
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Coverdale
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Lau
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. Wong
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Eu
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. J. Hicks
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:University of Melbourne
                     address:
                        name:University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               type:Person
               name:H. M. Prince
               affiliation:
                     name:Peter MacCallum Cancer Centre
                     address:
                        name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                        type:PostalAddress
                     type:Organization
                     name:University of Melbourne
                     address:
                        name:University of Melbourne, Melbourne, Australia
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
      description:Radio-labelling of blood cells is an established technique for evaluating in vivo migration of normal cells to sites of pathology such as infection and haemorrhage. A limitation of cellular immunotherapies to induce anti-tumour responses is in part due to the uncertain ability of cellular effectors to reach their intended target. We extended the approach of cell radiolabelling to accurately examine the in vivo distribution of cellular immunotherapy with ex-vivo macrophage activated killer (MAK) cells. We describe the use of two methods of cell labelling for tracking the destination of autologous-derived macrophage activated killer (MAK®) cells linked to the bi-specific antibody MDX-H210 delivered either by intravenous (i.v.) or intraperitoneal (i.p.) injection in ten patients with peritoneal relapse of epithelial ovarian carcinoma. Our results demonstrate the feasibility of generating high numbers and purity of GMP quality MAK cells, which can be radiolabelled with 18F-FDG or 111In-oxime. MAK cell administration produced minimal infusional toxicity and demonstrated a reproducible pattern of in vivo distribution and active in vivo tracking to sites of known tumour following 8 of 16 i.v. infusions or 4 of 6 i.p. infusions. However, the leakage of 18F-FDG limited the ability to confidently confirm the tracking of MAK cells to tumour in all cases and improved PET labels are required. The addition of MDX-H210 bispecific antibody did not alter the distribution of cells to tumour sites, but did accelerate the clearance of i.v. administered MAK cells from the pulmonary circulation. This data demonstrates that cellular cancer immunotherapies may be successfully delivered to the sites of active tumour following either i.v. or i.p. injection in a proportion of patients with metastatic cancer. Incorporation of tracking studies in early cycles of cellular immunotherapy may allow selection of patients who demonstrate successful targeting of the immunotherapy for ongoing treatment.
      datePublished:2006-05-30T00:00:00Z
      dateModified:2006-05-30T00:00:00Z
      pageStart:155
      pageEnd:163
      sameAs:https://doi.org/10.1007/s00262-006-0181-3
      keywords:
         Immunotherapy
         Macrophage
         Radiolabel
         PET
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-006-0181-3/MediaObjects/262_2006_181_Fig4_HTML.jpg
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:56
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:D. Ritchie
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:University of Melbourne
                  address:
                     name:University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L. Mileshkin
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:University of Melbourne
                  address:
                     name:University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Wall
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Bartholeyns
            affiliation:
                  name:Immuno-Designed Molecules
                  address:
                     name:Immuno-Designed Molecules, Paris, France
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Thompson
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Coverdale
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Lau
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. Wong
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Eu
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. J. Hicks
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:University of Melbourne
                  address:
                     name:University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            type:Person
            name:H. M. Prince
            affiliation:
                  name:Peter MacCallum Cancer Centre
                  address:
                     name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
                     type:PostalAddress
                  type:Organization
                  name:University of Melbourne
                  address:
                     name:University of Melbourne, Melbourne, Australia
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:56
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
         type:PostalAddress
      name:University of Melbourne
      address:
         name:University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
         type:PostalAddress
      name:University of Melbourne
      address:
         name:University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
         type:PostalAddress
      name:Immuno-Designed Molecules
      address:
         name:Immuno-Designed Molecules, Paris, France
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
         type:PostalAddress
      name:University of Melbourne
      address:
         name:University of Melbourne, Melbourne, Australia
         type:PostalAddress
      name:Peter MacCallum Cancer Centre
      address:
         name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
         type:PostalAddress
      name:University of Melbourne
      address:
         name:University of Melbourne, Melbourne, Australia
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:D. Ritchie
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:University of Melbourne
            address:
               name:University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:L. Mileshkin
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:University of Melbourne
            address:
               name:University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:D. Wall
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:J. Bartholeyns
      affiliation:
            name:Immuno-Designed Molecules
            address:
               name:Immuno-Designed Molecules, Paris, France
               type:PostalAddress
            type:Organization
      name:M. Thompson
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:J. Coverdale
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:E. Lau
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:J. Wong
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:P. Eu
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:R. J. Hicks
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:University of Melbourne
            address:
               name:University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      name:H. M. Prince
      affiliation:
            name:Peter MacCallum Cancer Centre
            address:
               name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
               type:PostalAddress
            type:Organization
            name:University of Melbourne
            address:
               name:University of Melbourne, Melbourne, Australia
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
      name:University of Melbourne, Melbourne, Australia
      name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
      name:University of Melbourne, Melbourne, Australia
      name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
      name:Immuno-Designed Molecules, Paris, France
      name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
      name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:Department of Diagnostic Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
      name:University of Melbourne, Melbourne, Australia
      name:Department of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, Australia
      name:University of Melbourne, Melbourne, Australia
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(169)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

3.99s.